Bioxcel therapeutics, inc. (btai) class action notice: robbins llp reminds investors of lead plaintiff deadline in class action against bioxcel therapeutics, inc.

San diego--(business wire)---- $btai #bxcl501--bioxcel therapeutics, inc. (btai) clinical trial failed to adhere to data integrity controls.

BTAI Ratings Summary

BTAI Quant Ranking